Nexstim Wins NBS 6 System Order in US

MT Newswires · 2d ago
02:19 AM EDT, 08/19/2026 (MT Newswires) -- Nexstim (NXTMH.HE) secured a contract to provide its NBS 6 system to a US-based customer, according to a Wednesday release. The medical technology company will deliver the US Food and Drug Administration-approved NBS 6 Therapy Base Unit, which is indicated for the treatment of major depressive disorder in adults and adolescents and as an adjunct therapy for obsessive-compulsive disorder.